189 related articles for article (PubMed ID: 35063629)
1. A case of normal C1 esterase inhibitor hereditary angioedema successfully treated with berotralstat.
Kelbel T
Ann Allergy Asthma Immunol; 2022 Apr; 128(4):462-463. PubMed ID: 35063629
[No Abstract] [Full Text] [Related]
2. Evaluation of the safety and effectiveness of berotralstat for patients with hereditary angioedema: Report of six cases.
Takamura S; Nakamura K; Fukuda T
J Dermatol; 2023 Nov; 50(11):1506-1508. PubMed ID: 37721445
[No Abstract] [Full Text] [Related]
3. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema.
Valerieva A; Staevska M; Jesenak M; Hrubiskova K; Sobotkova M; Zachova R; Hakl R; Andrejevic S; Suiter T; Grivcheva-Panovska V; Karadza-Lapic L; Soteres D; Shapiro R; Rumbyrt J; Tachdjian R; Mehta V; Hsu FI; Zanichelli A
J Allergy Clin Immunol Pract; 2020 Feb; 8(2):799-802. PubMed ID: 31437566
[No Abstract] [Full Text] [Related]
4. A review of berotralstat for the treatment of hereditary angioedema.
Farkas H; Balla Z
Expert Rev Clin Immunol; 2023 Feb; 19(2):145-153. PubMed ID: 36408587
[TBL] [Abstract][Full Text] [Related]
5. Berotralstat for the prophylaxis of hereditary angioedema-Real-world evidence data from the United Kingdom.
Ahuja M; Dorr A; Bode E; Boulton APR; Buckland M; Chee S; Dalley C; Denman S; Ekbote A; Elkhalifa S; El-Shanawany T; Eren E; Herwadkar A; Garcez T; Ghanta H; Grammatikos A; Grigoriadou S; Jain R; Lorenzo L; Manson A; Moon E; Murng S; Murphy A; Mutlu L; Peters N; Sooriyakumar K; Stroud C; Townsend K; Yellon RL; Yong P; Kiani-Alikhan S
Allergy; 2023 May; 78(5):1380-1383. PubMed ID: 36609839
[No Abstract] [Full Text] [Related]
6. New drugs to treat hereditary angioedema.
Scheinfeld N
Skinmed; 2013; 11(6):357-9. PubMed ID: 24517042
[No Abstract] [Full Text] [Related]
7. Three new drugs for hereditary angioedema.
Med Lett Drugs Ther; 2010 Aug; 52(1345):66-7. PubMed ID: 20724964
[No Abstract] [Full Text] [Related]
8. Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency.
Suffritti C; Sartorio S; Berra S; Janu VP; Caccia S; Zanichelli A
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):963-965.e1. PubMed ID: 36379410
[No Abstract] [Full Text] [Related]
9. Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency.
Belbézier A; Boccon-Gibod I; Bouillet L
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2490-2491. PubMed ID: 33556593
[No Abstract] [Full Text] [Related]
10. Successful C1 esterase inhibitor therapy in a child with a novel type 3 hereditary angioedema-like syndrome.
Rasmussen JL; Park MA; Fischer PR
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):462-3. PubMed ID: 22626603
[No Abstract] [Full Text] [Related]
11. Medical algorithm: Management of C1 inhibitor hereditary angioedema.
Caballero T; Cabañas R; Pedrosa M
Allergy; 2022 Mar; 77(3):1060-1063. PubMed ID: 34587298
[No Abstract] [Full Text] [Related]
12. Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema.
Alizadeh Aghdam M; Hofman ZLM; Meertens M; Lebens A; Hack CE; Knulst AC; Maas C; Röckmann H
Allergy; 2022 Dec; 77(12):3673-3676. PubMed ID: 35837765
[No Abstract] [Full Text] [Related]
13. Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial.
Kiani-Alikhan S; Gower R; Craig T; Wedner HJ; Kinaciyan T; Aygören-Pürsün E; Banerji A; Bernstein JA; Anderson J; Collis P; Johnston DT; Desai B; Tomita D; Gagnon R; Tachdjian R; Soteres DF; Farkas H; Caballero T; McNeil D; Jacobs J; Lumry WR;
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):733-743.e10. PubMed ID: 38122865
[TBL] [Abstract][Full Text] [Related]
14. Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema.
Rizk C; Karsh J; Santucci S; Yang W
CMAJ; 2013 Jun; 185(9):791-2. PubMed ID: 23610020
[No Abstract] [Full Text] [Related]
15. Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat.
Riedl MA; Soteres D; Sublett JW; Desai B; Tomita D; Collis P; Bernstein JA;
Ann Allergy Asthma Immunol; 2024 Apr; 132(4):505-511.e1. PubMed ID: 38006972
[TBL] [Abstract][Full Text] [Related]
16. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
Stehlin F; Ribi C
Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of C1 esterase inhibitor protein concentrate in the management of hereditary angioedema of oropharyngeal tissue.
Yigit M; Sogut O; Lisar H; Yigit E
Niger J Clin Pract; 2018 Apr; 21(4):531-533. PubMed ID: 29607870
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
20. Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate.
Gorman PJ
Can Fam Physician; 2008 Mar; 54(3):365-6. PubMed ID: 18337530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
